FOR IMMEDIATE
RELEASE
4 December 2009
Hygea VCT plc
("Hygea" or the "Company")
Appointment of Corporate Broker
The Board is pleased to announce the appointment of Matrix Corporate
Capital LLP ("Matrix") as corporate broker to the Company with
immediate effect.
Amongst their services, Matrix have agreed to make a market in
Hygea's shares and to report on the secondary market in the Company's
shares.
John Hustler, a Director, comments: 'Hygea is pleased to have
appointed Matrix as the Company's corporate broker and the Board hope
that their appointment combined with the recent cash positive
investment realizations can narrow the gap between the Company's net
asset value per share and share price in the market.'
Beaumont Cornish Limited will continue as the Company's Sponsor and
Financial Advisor.
Enquiries:
Charles Breese, Hygea VCT plc on 01280 703482 or
larpentnewton@btinternet.com
Roland Cornish, Beaumont Cornish Limited on 020 7628 3396
---END OF MESSAGE---
This announcement was originally distributed by Hugin. The issuer is
solely responsible for the content of this announcement.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.